首页> 美国卫生研究院文献>Cancer Science >Dose Dependence of 1‐O‐Hexyl‐235‐trimethylhydroquinone Promotion of Forestomach Carcinogenesis in Rats Pretreated with N‐Ethylnitrosourethane
【2h】

Dose Dependence of 1‐O‐Hexyl‐235‐trimethylhydroquinone Promotion of Forestomach Carcinogenesis in Rats Pretreated with N‐Ethylnitrosourethane

机译:1-O-己基-235-三甲基对苯二酚剂量依赖性促进N-乙基亚硝基氨基甲酸酯预处理的大鼠前胃癌致癌作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Post‐initiation dose‐dependent effects of the chemopreventive antioxidant 1‐O‐hexyl‐2,3,5‐trimethylhydroquinone (HTHQ), a potent inhibitor of heterocyclic amine‐induced mutagenesis and carcinogenesis, on the development of forestomach and tongue tumors were investigated in male F344 rats. Groups of 22 rats were treated with 0.01% ethylnitrosourethane (ENUR) as an initiator in the drinking water for 4 weeks, then placed on diet containing 1.0%, 0.5%, 0.25% or 0.125% HTHQ, or basal diet alone for 36 weeks. Further groups of 12 rats each were similarly treated with the different doses of HTHQ or given basal diet alone for 36 weeks without prior ENUR treatment. All animals were killed at week 40. Tongue papillary hyperplasia and papillomas tended to be increased in the groups treated with ENUR followed by 0.5–0.125% HTHQ, though there was no effect at the highest dose, in line with increased bromodeoxyuridine labeling indices. In the forestomach, the incidences of papillomas and carcinomas were also significantly elevated only in the group treated with ENUR followed by 0.125% HTHQ. Without ENUR pretreatment, papillary hyperplasia was found in the 1–0.125% HTHQ groups and the labeling index was also increased, though without clear dose dependence. The results indicate that HTHQ may have very weak or weak promotion potential for tongue and forestomach carcinogenesis, but that both minimum and maximum thresholds for active dose levels may exist.
机译:研究了化学预防性抗氧化剂1-O-己基-2,3,5-三甲基对苯二酚(HTHQ)(一种有效的杂环胺诱导的诱变和致癌性抑制剂)在启动后的剂量依赖性效应,对前胃癌和舌头肿瘤的发展产生了影响在雄性F344大鼠中。 22只大鼠的组在饮用水中用0.01%的乙基亚硝基氨基甲酸酯(ENUR)作为引发剂治疗4周,然后接受含有1.0%,0.5%,0.25%或0.125%HTHQ的饮食或仅基础饮食36周。其他组的每只12只大鼠也接受了不同剂量的HTHQ相似的治疗,或单独给予基础饮食36周,而未进行ENUR治疗。在第40周时将所有动物处死。用ENUR,0.5-0.125%HTHQ处理的组中,舌乳头状增生和乳头状瘤倾向于增加,尽管在最高剂量下无作用,与溴脱氧尿苷标记指数的增加一致。在前胃中,乳头状瘤和癌的发生率也仅在ENUR + 0.125%HTHQ治疗组中显着升高。未经ENUR预处理,尽管没有明显的剂量依赖性,但在1-0.125%的HTHQ组中发现了乳头状增生,标记指数也增加了。结果表明,HTHQ对舌头和前胃癌的致癌作用可能具有非常弱的促进能力,但是活性剂量水平的最小和最大阈值都可能存在。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号